![China - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights](/landing/img/reports/china-vaccines-for-human-medicine-market-analysis-forecast-size-trends-and-insights.webp)
China - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVaccines Prices in China
China Vaccines Export Price in December 2021
In December 2021, the vaccines price stood at $2.3K per kg (FOB, China), with a decrease of -5.1% against the previous month. Overall, the export price continues to indicate a perceptible contraction. The pace of growth appeared the most rapid in March 2021 an increase of 53% against the previous month. As a result, the export price attained the peak level of $5,430 per kg; afterwards, it flattened through to December 2021.
There were significant differences in the average prices for the major export markets. In December 2021, the country with the highest price was Pakistan ($12.5K per kg), while the average price for exports to Kyrgyzstan ($531 per kg) was amongst the lowest.
From January 2021 to December 2021, the most notable rate of growth in terms of prices was recorded for supplies to Uzbekistan (+24.2%), while the prices for the other major destinations experienced more modest paces of growth.
China Vaccines Exports
In December 2021, vaccines exports from China amounted to 530 tons, picking up by 10% on the previous month's figure. Overall, exports showed a buoyant expansion. The most prominent rate of growth was recorded in July 2021 when exports increased by 150% against the previous month. The exports peaked at 718 tons in October 2021; however, from November 2021 to December 2021, the exports remained at a lower figure.
In value terms, vaccines exports amounted to $1.2B (IndexBox estimates) in December 2021. Over the period under review, exports recorded a prominent expansion. The most prominent rate of growth was recorded in February 2021 when exports increased by 81% m-o-m. The exports peaked at 2.5M tons in July 2021; however, from August 2021 to December 2021, the exports stood at a somewhat lower figure.
China Vaccines Exports by Country
Bangladesh (228 tons) was the main destination for vaccines exports from China, accounting for a 43% share of total exports. Moreover, vaccines exports to Bangladesh exceeded the volume sent to the second major destination, the United Arab Emirates (71 tons), threefold. The third position in this ranking was held by Mozambique (33 tons), with a 6.2% share.
From January 2021 to December 2021, the average monthly rate of growth in terms of volume to Bangladesh amounted to +96.1%. Exports to the other major destinations recorded the following average monthly rates of exports growth: the United Arab Emirates (-1.1% per month) and Mozambique (+38.3% per month).
In value terms, the largest markets for vaccines exported from China were Bangladesh ($342M), Pakistan ($179M) and Indonesia ($145M), together comprising 56% of total exports.
Pakistan, with a CAGR of +82.1%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
This report provides an in-depth analysis of the vaccine market in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the antisera market in China.
This report provides an in-depth analysis of the biological product market in China.
This report provides an in-depth analysis of the market for human and animal blood in China.
This report provides an in-depth analysis of the veterinary medicine vaccines market in China.
This report provides an in-depth analysis of the global vaccine market.
This report provides an in-depth analysis of the global antisera market.
This report provides an in-depth analysis of the global biological product market.
This report provides an in-depth analysis of the global market for human and animal blood.
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G